Factors affecting the outcomes in stable chronic obstructive pulmonary disease patients at an Army Central Hospital

被引:0
作者
Nurwulandari, Nunik U. [1 ]
Zazuli, Zulfan [1 ]
Wihastuti, Retno [2 ]
Wikaningtyas, Pratiwi [1 ]
机构
[1] Bandung Inst Technol, Sch Pharm, Dept Pharmacol Clin Pharm, Bandung 40132, Indonesia
[2] Gatot Soebroto Army Cent Hosp, Dept Pulmonol, Jakarta, Indonesia
来源
PHARMACY PRACTICE-GRANADA | 2024年 / 22卷 / 01期
关键词
COPD; clinical outcomes; factors; therapeutic outcomes; LUNG-FUNCTION; RISK-FACTORS; ALCOHOL-CONSUMPTION; COPD; BURDEN; COMORBIDITIES; TUBERCULOSIS; PREVALENCE; MANAGEMENT; SYMPTOMS;
D O I
10.18549/PharmPract.2024.1.2903
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Of the four Asian countries, Indonesian COPD patients have the worst clinical features, which puts them at a high risk for treatment failure. There are a number of variables and patient traits that influence clinical results as a predictor of therapy outcomes. Objective: to identify the contributing components and how much they influence COPD patients' therapy results. Methods: This cross-sectional descriptive-observational study at a tertiary army hospital involved 74 patients. A questionnaire and medical records were utilized to obtain sociodemographic characteristics and clinical data. Correlation and logistic regression analysis were conducted to identify significant factors. Results: The results showed that tumor/cancer comorbidities affected the worsening of CAT values (OR=10.89, 95%CI=1.01-117.23, p=0.049), use of ICS/LABA drugs affected the improvement of mMRC values (OR= 0.26, 95%CI=0.08-0.84, p=0.024), history of TBC disease affected the increase in exacerbation severity (OR=7.25, 95%CI=1.05-50.23, p=0.045), age from smoking >20 years affected the reduction in exacerbation severity (OR=0.03, 95%CI=0.002-0.61, p=0.022). History of alcohol use (OR=7.26 and 167.56, p=0.014 and 0.004) and comorbid pneumonia (OR=28.14 and 44.25, p=0.035 and 0.014) contributed to an increase in the frequency of exacerbations and hospitalization per year. Medium economic status affects the decrease in hospitalizations per year (OR=0.06, 95%CI=0.00-0.91, p=0.043) while the diagnosis of severe COPD and history of alcohol affected the decrease in COPD severity (ABCD) (OR=0.12 and 0.24, p=0.039 and 0.009). Conclusion: comorbidities, disease history, history of alcohol use, COPD status and the use of COPD medications contributed to variations therapeutic outcomes COPD patients. Therefore, it must be taken into account when making clinical decisions.
引用
收藏
页数:16
相关论文
共 61 条
  • [1] Asyrofy A, 2021, NURSCOPE J Penelit dan Pemikir Ilm Keperawatan, V7, P13
  • [2] Audrina GW, 2014, J Statisika, V3, pD36
  • [3] Oxidative stress-based therapeutics in COPD
    Barnes, Peter J.
    [J]. REDOX BIOLOGY, 2020, 33
  • [4] Chronic obstructive pulmonary disease
    Barnes, Peter J.
    Burney, Peter G. J.
    Silverman, Edwin K.
    Celli, Bartolome R.
    Vestbo, Jorgen
    Wedzicha, Jadwiga A.
    Wouters, Emiel F. M.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [5] Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries
    Beran, David
    Zar, Heather J.
    Perrin, Christophe
    Menezes, Ana M.
    Burney, Peter
    [J]. LANCET RESPIRATORY MEDICINE, 2015, 3 (02) : 159 - 170
  • [6] Prevalence and Population-Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study
    Burney, Peter
    Patel, Jaymini
    Minelli, Cosetta
    Gnatiuc, Louisa
    Amaral, Andre F. S.
    Kocabas, Ali
    Cherkaski, Hamid Hacene
    Gulsvik, Amund
    Nielsen, Rune
    Bateman, Eric
    Jithoo, Anamika
    Mortimer, Kevin
    Sooronbaev, Talant M.
    Lawin, Herve
    Nejjari, Chakib
    Elbiaze, Mohammed
    El Rhazi, Karima
    Zheng, Jin-Ping
    Ran, Pixin
    Welte, Tobias
    Obaseki, Daniel
    Erhabor, Gregory
    Elsony, Asma
    Osman, Nada Bakri
    Ahmed, Rana
    Nizankowska-Mogilnicka, Ewa
    Mejza, Filip
    Mannino, David M.
    Barbara, Cristina
    Wouters, Emiel F. M.
    Idolor, Luisito F.
    Loh, Li-Cher
    Rashid, Abdul
    Juvekar, Sanjay
    Gislason, Thorarinn
    Al Ghobain, Mohamed
    Studnicka, Michael
    Harrabi, Imed
    Denguezli, Meriam
    Koul, Parvaiz A.
    Jenkins, Christine
    Marks, Guy
    Jogi, Rain
    Hafizi, Hasan
    Janson, Christer
    Tan, Wan C.
    Aquart-Stewart, Althea
    Mbatchou, Bertrand
    Nafees, Asaad Ahmed
    Gunasekera, Kirthi
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (11) : 1353 - 1365
  • [7] Definition and Nomenclature of Chronic Obstructive Pulmonary Disease Time for Its Revision
    Celli, Bartolome
    Fabbri, Leonardo
    Criner, Gerard
    Martinez, Fernando J.
    Mannino, David
    Vogelmeier, Claus
    Montes de Oca, Maria
    Papi, Alberto
    Sin, Don D.
    Han, MeiLan K.
    Agusti, Alvar
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (11) : 1317 - 1325
  • [8] Chairunnissa T., 2016, Al-Ihsan Bandung, V2017, P154
  • [9] Inhaler Technique and Adherence to Inhaled Medications among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam
    Chau Quy Ngo
    Dung Minh Phan
    Giap Van Vu
    Phu Ngoc Dao
    Phuong Thu Phan
    Hanh Thi Chu
    Long Hoang Nguyen
    Giang Thu Vu
    Giang Hai Ha
    Tung Hoang Tran
    Bach Xuan Tran
    Latkin, Carl A.
    Ho, Cyrus S. H.
    Ho, Roger C. M.
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (02)
  • [10] Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients
    Cheng, Shih-Lung
    Lin, Ching-Hsiung
    Wang, Chin-Chou
    Chan, Ming-Cheng
    Hsu, Jeng-Yuan
    Hang, Liang-Wen
    Perng, Diahn-Warng
    Yu, Chong-Jen
    Wang, Hao-Chien
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (01) : 429 - 435